HNRNPK lactylation acts as a metabolic sensor coupling lactate accumulation to pathogenic Jag2 splicing and offers a precise therapeutic strategy to limit inflammation and preserve cardiac function in ischemic heart disease.
Abstract
Background
Myocardial ischemia/reperfusion injury triggers profound metabolic reprogramming and lactate accumulation. However, how this metabolic stress regulates inflammatory gene expression remains poorly understood. We hypothesized that lactylation, a lactate-derived posttranslational modification, links metabolic stress to aberrant RNA splicing and cardiac inflammation through the RNA-binding protein HNRNPK (heterogeneous nuclear ribonucleoprotein K).
Methods
We analyzed atrial tissues from patients undergoing cardiopulmonary bypass and murine ischemia/reperfusion hearts to assess lactylation dynamics. Lactylation-specific proteomics, RNA sequencing, and crosslinking and immunoprecipitation followed by quantitative polymerase chain reaction were used to identify HNRNPK targets. Mechanisms were defined using site-directed mutagenesis (HNRNPK-K405R), isoform-specific overexpression, and a therapeutic splice-switching antisense oligonucleotide in mice and cardiomyocytes.
Results
Reperfusion significantly increased global protein lactylation in human and murine myocardium. Proteomics identified HNRNPK as a key target, specifically lactylated at lysine 405 (K405la). Ischemia-induced K405la promoted HNRNPK binding to Jag2 pre-mRNA, suppressing exon 10 skipping and shifting splicing from the Jag2 (Jagged2) short (Jag2-S) to the long (Jag2-L) isoform. Jag2-L, but not Jag2-S, exhibited high affinity for Notch1, hyperactivating Notch-NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) signaling and exacerbating inflammation and infarct size. Mice expressing a lactylation-deficient variant (HNRNPK-K405R) were protected from ischemia/reperfusion injury. Treatment with a specific antisense oligonucleotide (Jag2-i9) that blocks the HNRNPK-Jag2 interaction prevented Jag2-L production and attenuated cardiac dysfunction.
Conclusions
HNRNPK lactylation acts as a metabolic sensor coupling lactate accumulation to pathogenic Jag2 splicing. Targeting this metabolic-splicing axis offers a precise therapeutic strategy to limit inflammation and preserve cardiac function in ischemic heart disease.
REGISTRATION
URL: http://www.chictr.org.cn; Unique identifier: ChiCTR2400091959.
It is systematically elucidated that SRPK3 acts as a detrimental regulator in myocardial I/R injury by inducing lethal autophagy via the KLF3-mTOR axis and offer a promising therapeutic target for managing ischemic heart disease.
Yun Xing, Saiyang Xie, Nan Zhao et al.· Acta Pharmacologica Sinica· 0 citations
BACKGROUND
Myocardial ischemia/reperfusion (MI/R) injury remains a major clinical challenge characterized by inflammation and progressive cardiomyocyte loss. Although pyroptosis is known to drive this pathogenesis, the upstream molecular switches that trigger the pyroptotic cascade remain poorly understood. Here, we in...
Xiao-Wei Niu, Peng Lei, Tian-Kui Shuai et al.· Biochimica et Biophysica Act...· 0 citations
It is demonstrated that lactate drives sustained renal damage through posttranslational lactylation of the RNA helicase DDX18, and protein lactylation is established as a regulatory mechanism governing RNA helicase nucleolar localization and subsequent control of mRNA stability, revealing a potential therapeutic target...
Li-Jun Dong, Jing-Wen Xie, Meng-Yuan Tao et al.· Journal of Clinical Investig...· 0 citations
It is shown that hypoxia-induced histone lactylation (Kla) upregulates FTO via HIF1a-P300 interaction; lactylation-driven FTO then promotes late-stage M2 polarization by stabilizing Arg1 mRNA through the m6A-YTHDF2 axis.
Xing-Wang Zhao, Meng-Jie Zhang, Jun Yin et al.· Cell Reports· 0 citations
Trimethylamine N-oxide (TMAO), a gut microbiota-derived metabolite, promotes cardiac hypertrophy, yet the molecular mechanisms linking microbial metabolism to cardiac gene expression remain incompletely defined. Ketohexokinase (KHK), the rate-limiting enzyme of fructose catabolism, is implicated in cardiac pathology, b...